Yu Huan, He Yuan, Mao Zhengxia, Dong Wenbing, Fu Xiaodong, Lei Xiaoping
Department of Neonatology.
Department of Gynaecology and Obstetrics, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Medicine (Baltimore). 2019 May;98(20):e15677. doi: 10.1097/MD.0000000000015677.
Hypertensive disorders during pregnancy (HDP), including gestational hypertension, preeclampsia (PE), and chronic hypertension, affect approximately 10% of pregnancies worldwide. PE was associated with elevated blood pressure (BP) in the offspring confirmed by previous literature. No previous systematic review has investigated the associations between the subtypes of HDP and BP in offspring. Therefore, from the published literature, the present systematic review and meta-analysis aims to reach to a clear consensus on this topic.
The Cochrane Handbook for Systematic Reviews of Interventions was used to structure our methodological approach, and the Preferred Reporting Items for Systematic Reviews and Meta Analyses Protocols guidelines to this protocol. We will include cohort, case-control, and cross-sectional studies, in which HDP or its subtypes were reported and BP in the offspring was the outcome of interest. A systematic search of PubMed, Embase, the Cochrane library, and Web of Science will be conducted according to a specific search strategy. The titles and abstracts of all literature will be reviewed independently by 2 authors. A standardized data collection form will be used for data extraction. The overall pooled estimates will be calculated by meta-analysis in Revman 5.3 based on an inverse variance method. According to the heterogeneity by the I, a random-effect model or a fixed-effect model will be chosen to pool data. Risk of bias and quality of the studies will be assessed by a suitable bias classification tool.
This study will provide high-quality evidence of the effects in offspring BP, which were influenced by different subtypes of HDP.
This systematic review will infer a conclusion on the associations between different subtypes of HDP and BP in offspring.
Due to the data come from the published study, the present systematic review and meta-analysis does not require ethics approval. Findings will be published in a peer-reviewed journal.
Supporting data can be found at the International Prospective Register of Systematic Reviews (PROSPERO) website, with registration number CRD 42018110872.
妊娠期高血压疾病(HDP),包括妊娠期高血压、子痫前期(PE)和慢性高血压,影响全球约10%的妊娠。既往文献证实,PE与后代血压(BP)升高有关。此前尚无系统评价研究HDP各亚型与后代血压之间的关联。因此,本系统评价和荟萃分析旨在从已发表的文献中就该主题达成明确共识。
采用《Cochrane干预措施系统评价手册》构建我们的方法学方法,并遵循系统评价和荟萃分析方案的首选报告项目指南制定本方案。我们将纳入队列研究、病例对照研究和横断面研究,这些研究报告了HDP或其亚型,且后代血压是感兴趣的结局。将根据特定的检索策略对PubMed、Embase、Cochrane图书馆和Web of Science进行系统检索。所有文献的标题和摘要将由2名作者独立审查。将使用标准化的数据收集表进行数据提取。将在Revman 5.3中基于逆方差法通过荟萃分析计算总体合并估计值。根据I2的异质性,将选择随机效应模型或固定效应模型汇总数据。将通过合适的偏倚分类工具评估研究的偏倚风险和质量。
本研究将提供关于不同亚型HDP对后代血压影响的高质量证据。
本系统评价将推断出HDP不同亚型与后代血压之间关联的结论。
由于数据来自已发表的研究,本系统评价和荟萃分析无需伦理批准。研究结果将发表在同行评审期刊上。
支持数据可在国际前瞻性系统评价注册库(PROSPERO)网站上找到,注册号为CRD 42018110872。